Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
4207829 | Clinics in Chest Medicine | 2007 | 19 Pages |
Abstract
Chronic obstructive pulmonary disease is a treatable disease characterized by progressive airflow limitation. Prevention of disease progression; improvement of symptoms, exercise tolerance, and health status; and decrease in exacerbations and mortality are the goals of management. Inhaled short-acting bronchodilators are recommended for symptoms in mild disease, whereas inhaled long-acting bronchodilators are recommended for maintenance therapy of daily symptoms. When symptoms are not controlled using one bronchodilator, combining bronchodilators may be more effective. Combining a long-acting β-agonist with an inhaled corticosteroid is more effective than either agent alone. Several novel therapies are in different stages of development.
Related Topics
Health Sciences
Medicine and Dentistry
Pulmonary and Respiratory Medicine
Authors
Nicola A. MD, MS, Amir MD,